Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma

19 Aug 2022

Abstract excerpt

AIMS: Gliomas are the primary malignant brain tumor and characterized as the striking cellular heterogeneity and intricate tumor microenvironment (TME), where chemokines regulate immune cell trafficking by shaping local networks. This study aimed to construct a chemokine-based gene signature to evaluate the prognosis and therapeutic response in glioma. METHODS: In this study, 1024 patients (699 from TCGA and 325...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine receptors and signaling
Share to Glioma Diagnosis and Treatment
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35985661
DOI: 10.1111/cns.13944

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in gliomaPMID 35985661Read ↗

An Immune Related Gene Signature from Chemokines and Chemokine Receptors to Predict Tumor Prognosis and Immune Microenvironment Alteration in Lower-Grade Glioma (LGG) Based on Large-Scale Transcriptome Profile AnalysesSemantic proximity Read ↗

The Prognostic Value of Risk Score Based on Immunogenenomic Landscape Analysis in GliomaSemantic proximity Read ↗

Molecular subtypes and prognostic analysis of cytokine-related genes in gliomasSemantic proximity Read ↗

Molecular subtyping of glioblastoma based on immune-related genes for prognosisSemantic proximity Read ↗

MUL1, an Immune Chemokine-Related Gene, Regulates Glioma Cell Proliferation and Migration: Insights from Functional and Mechanistic StudiesSemantic proximity Read ↗

Development of An Inflammatory Response-Related Gene Signature To Predict Prognosis and Immunotherapy Response For Patients With GliomaSemantic proximity Read ↗

Development of a tumor microenvironment-related prognostic signature in glioma to predict immune landscape and potential therapeutic drugs.Semantic proximity Read ↗

Development of a prognostic model of glioma based on immune‑related genesSemantic proximity Read ↗

A Novel MALT1-related Immune Prognostic Signature and Targeted Drug Screening for GlioblastomaSemantic proximity Read ↗

Identification of Prognostic Biomarkers and Immunotherapeutic Targets with CXC Chemokines in Glioblastoma Multiforme Using Integrated Bioinformatic AnalysisSemantic proximity Read ↗

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale AnalysisSemantic proximity Read ↗

Development and Validation of a Glioma-Associated Mesenchymal Stem Cell-Related Gene Prognostic Index for Predicting Prognosis and Guiding Individualized Therapy in GliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.